June 15th 2021
Recommendations for treating HER2-positive metastatic breast cancer with newer HER2-targeted treatment approaches and considerations regarding their adoption into clinical practice.
May 20th 2021
Paul K. Paik, MD, discusses the spectrum of targeted therapy in non-small cell lung cancer.
December 21st 2020
Key opinion leader discusses considerations for adult patients with spinal muscular atrophy (SMA) including disease burden, treatment evaluation, and the use of real-world evidence.